The National Medical Products Administration (NMPA) has granted import approval to US firm Alcon Laboratories, Inc. for its innovative intraocular lens, marking it as the 197th innovative medical device to be approved by the bureau.
Product Features and Benefits
The product in question is a one-piece posterior chamber intraocular lens that incorporates patented wavefront shaping technology. This technology is designed to fully utilize the light entering the eye, addressing common side effects such as halos and other visual interferences associated with diffractive intraocular lenses. The lens is indicated for adult patients with preoperative corneal astigmatism of less than 1.00D and for aphakic eyes following extracapsular cataract extraction.
Enhancing Visual Correction and Reducing Presbyopia Impact
The primary phase of intraocular lens implantation is for visual correction. This product is engineered to mitigate the effects of presbyopia on patients’ near, medium, and far vision by expanding the depth of focus. It maintains substantial far vision while extending the visual range from long distance to functional close range, thereby reducing patients’ reliance on glasses.-Fineline Info & Tech
